
Nimesulide by Zyntex is a high-purity non-steroidal anti-inflammatory drug (NSAID) with selective COX-2 inhibitory activity, primarily used as an API for acute pain and primary dysmenorrhea.
Exceptional selective inhibition of the COX-2 enzyme provides a major competitive advantage in the management of localized inflammation. This medicinal compound works by reducing the synthesis of prostaglandins while exhibiting a lower affinity for the COX-1 enzyme compared to traditional NSAIDs. It helps manufacturers develop formulations that target pain effectively with a specific focus on short-term relief. For instance, Nimesulide is widely utilized for the treatment of primary dysmenorrhea and symptomatic osteoarthritis. Consequently, it serves as a powerful tool in modern analgesic therapy. As a result, Zyntex ensures rigorous assay testing and strict control of related substances for our supply, ensuring maximum chemical stability during your formulation processes.
Moreover, Zyntex supplies specialized grades for topical applications and transdermal research. This compound acts as a critical active agent in medicated plasters and gels designed to treat musculoskeletal injuries. It pushes the boundaries of localized therapy by offering deep tissue penetration without the high systemic exposure levels of oral administration. At the same time, it serves as a crucial reference standard for bioequivalence studies and pharmaceutical quality control. In short, our product serves as a dependable “inflammatory mediator.” It supports both the precision of clinical medicine and the stability requirements of global drug manufacturing.
Recently, scientific interest in its application for geriatric pain management and specialized pediatric formulations has been carefully monitored under strict regulatory guidelines. It provides a stable chemical route for developing rapid-dissolve granules that offer convenience for patients with swallowing difficulties. Because of this, Zyntex offers refined grades designed to meet the rigorous specifications of modern pharmacopeias and bioavailability research. Ultimately, choosing Zyntex secures a reliable and transparent pharmaceutical supply chain. We balance sulfonamide chemistry expertise with rigorous purity monitoring and safety documentation. To conclude, our commitment ensures your Nimesulide applications achieve the highest levels of therapeutic reliability and purity.
This high-potency anti-inflammatory active is essential in these four primary areas:
Rapid treatment for dental and postoperative pain. Thus, it is vital for achieving quick patient comfort and relief.
Key active in topical gels for sprains and strains. Undoubtedly, it is critical for reducing localized swelling and stiffness.
Effective for primary dysmenorrhea treatment. Consequently, it aids in managing cycle-related inflammatory symptoms.
High-purity starting material for advanced research. Specifically, it supports the development of new selective NSAID therapies.
| Parameter | Standard Value |
|---|---|
| Product Name | Nimesulide |
| Melting Point | 143 – 147 °C |
| Assay (Purity) | ≥ 99.0% |
| CAS Number | 51803-78-2 |
📝 Safety & Handling: Nimesulide must be handled as a potent pharmacological active. Therefore, use full personal protective equipment including lab coats, chemical-resistant gloves, and safety goggles. Avoid generating or breathing dust. Store in a cool, dry, and dark environment, as the compound is sensitive to light. Strictly follow local regulatory requirements regarding its distribution and use. Always consult the Safety Data Sheet (SDS) for detailed handling and toxicity information.